Raloxifene-4'-D-glucuronide D4 lithium salt

Ref. 3D-MR09928

Produktinformation

• Name: Raloxifene-4'-D-glucuronide D4 lithium salt
• Marke: Biosynth
• Beschreibung: Raloxifene-4'-D-glucuronide D4 lithium salt is a synthetic glycosylate drug, which belongs to the group of anti-estrogens. Raloxifene-4'-D-glucuronide D4 lithium salt is used for the treatment of postmenopausal osteoporosis and prevention of osteoporotic fractures in women with intact uterus. It has been shown to inhibit bone resorption, increase bone mineral density and reduce the incidence of vertebral fractures in postmenopausal women. Raloxifene-4'-D-glucuronide D4 lithium salt can be synthesized using a click chemistry reaction which involves the addition of an azide to an alkyne followed by copper catalysis and subsequent reduction with sodium borohydride. Synthesis of this compound can be achieved without any purification steps due to its high purity.

Chemische Eigenschaften

• Molekulargewicht: 659.66 g/mol
• Formel: C₃₄H₃₀NO₁₀SD₄·Li
• Reinheit: Min. 95%